PROFUND ADVISORS LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in NRIX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$854,776

-$183,615 QoQ

Shares Held

35,234

-47.4% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#107

of 210 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. NRIX ranks #68 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$854,776	35,234	-47.4%	Shares	Sole	2026-08-11
2026-03-31	$1,038,391	66,993	+93.7%	Shares	Sole	2026-04-27
2025-12-31	$655,982	34,580	+69.1%	Shares	Sole	2026-02-06
2025-09-30	$189,004	20,455	+24.5%	Shares	Sole	2025-11-06
2025-06-30	$187,171	16,433	-29.1%	Shares	Sole	2025-08-07
2025-03-31	$275,461	23,187	+1.2%	Shares	Sole	2025-05-08
2024-12-31	$431,511	22,904	+20.3%	Shares	Sole	2025-02-14
2024-09-30	$427,783	19,038	-25.6%	Shares	Sole	2024-11-14
2024-06-30	$534,021	25,588	-22.6%	Shares	Sole	2024-08-13
2024-03-31	$485,982	33,060	+91.8%	Shares	Sole	2024-05-08
2023-09-30	$135,451	17,233	-18.9%	Shares	Sole	2023-11-13
2023-06-30	$212,277	21,249	-19.4%	Shares	Sole	2023-08-10
2023-03-31	$234,067	26,359	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.